Monaghan Medical Corporation and Captis Continue to Partner to Improve Patient Outcomes
11 juin 2024 09h00 HE
|
Monaghan Medical Corporation
Monaghan & Captis announce a 2nd, 3-year contract. The agreement highlights the value of Monaghan, and Captis’ commitment to driving process efficiencies.
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
31 mai 2024 01h05 HE
|
Regeneron Pharmaceuticals, Inc.
Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent significantly reduced exacerbations and improved...
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
31 mai 2024 01h00 HE
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y. and PARIS, May 31, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by...
ENA Respiratory Receives USPTO Notice of Allowance for Key Patent Covering INNA-051, a First-in-Class Antiviral Innate Immunomodulator
08 mai 2024 04h00 HE
|
ENA Respiratory
MELBOURNE, Australia, May 08, 2024 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated...
ENA Respiratory Announces FDA IND Clearance for its Prophylactic Intranasal INNA-051 - a First-in-Class Antiviral Innate Immunomodulator
29 avr. 2024 04h00 HE
|
ENA Respiratory
MELBOURNE, Australia, April 29, 2024 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated...
[Latest] Global mHealth Market Size/Share Worth USD 374.6 Billion by 2032 at a 17.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
14 mars 2024 12h30 HE
|
Custom Market Insights
Austin, TX, USA, March 14, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “mHealth Market Size, Trends and Insights By Device Type (Cardiac Monitors,...
Monaghan Medical Corporation Attains ISO 14001 Certification for Environmental Management Excellence
27 févr. 2024 07h00 HE
|
Monaghan Medical Corporation
Monaghan Medical Corporation is proud to have achieved ISO 14001 certification
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 Inflammation
23 févr. 2024 01h00 HE
|
Regeneron Pharmaceuticals, Inc.
Priority Review granted based on positive results from two Phase 3 trials; if approved, Dupixent would be the only biologic therapy for COPD and the first new treatment approach for this disease in...
Wearable Medical Devices Market Size Worth USD 250.59 Billion in 2032 | Emergen Research
11 janv. 2024 08h31 HE
|
Emergen Research
Vancouver, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The global wearable medical devices market size was USD 26.80 Billion in 2022 and is expected to register a rapid revenue CAGR of 25.0% during the...
Monaghan Medical Celebrates Prestigious 2023 AARC Zenith Award Recognition
01 déc. 2023 11h47 HE
|
Monaghan Medical Corporation
MONAGHAN MEDICAL CELEBRATES PRESTIGIOUS 2023 AARC ZENITH AWARD RECOGNITION